Search - Prime Therapeutics

366 Results for GLP-1 Pipeline Update

AIS Health: FDA approves game-changing regimen for urothelial cancer, but will cost pose issue?

AIS Health

PA Sub-Categories: Specialty drugs Prime Article: In the News
AMCP Nexus 2024 in focus: Research details impact of gene therapy treatment for spinal muscular atrophy

Scott Leslie, director of health outcomes, shares more about the study “Real-World Case Series Study of Spinal Muscular Atrophy Pediatric Patients Treated With Onasemnogene Abeparvovec (Zolgensma)”

PA Sub-Categories: Specialty drugs Prime Article: Perspectives
Understanding specialty drug costs and how to manage them

A look at the specialty landscape and how Prime delivers value to employers

PA Sub-Categories: Specialty drugs Prime Article: Stories
Oncology Insights: February 2025

publications Learnings and impact generated from artificial intelligence (AI) systems February 18, 2025 Over time, technology has significantly contributed to health care advancements. Some of...